Tocilizumab and COVID-19: Timing of Administration Assessment
Domains
Human health and pathologyOrigin | Files produced by the author(s) |
---|
_ |
Origin | Files produced by the author(s) |
---|
Accord Elsevier CCSD : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03707363
Submitted on : Monday, July 22, 2024-11:01:57 AM
Last modification on : Thursday, November 7, 2024-2:22:25 PM